Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells. | Mol Cell | 2022 | 35594856 | PubTator, text mining | PubMed |
| SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication. | Commun Biol | 2022 | 35590097 | PubTator, text mining | PubMed |
| Stability of SARS-CoV-2-Encoded Proteins and Their Antibody Levels Correlate with Interleukin 6 in COVID-19 Patients. | mSystems | 2022 | 35582921 | PubTator, text mining | PubMed |
| Immune response in COVID-19: what is next? | Cell Death Differ | 2022 | 35581387 | PubTator, text mining | PubMed |
| Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model. | JCI Insight | 2022 | 35579953 | PubTator, text mining | PubMed |
| Repurposing the natural compounds as potential therapeutic agents for COVID-19 based on the molecular docking study of the main protease and the receptor-binding domain of spike protein. | J Mol Model | 2022 | 35578055 | PubTator, text mining | PubMed |
| A comprehensive SARS-CoV-2 and COVID-19 review, Part 1: Intracellular overdrive for SARS-CoV-2 infection. | Eur J Hum Genet | 2022 | 35577935 | PubTator, text mining | PubMed |
| Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects. | Front Immunol | 2022 | 35572592 | PubTator, text mining | PubMed |
| COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality. | Biomed Pharmacother | 2022 | 35569351 | PubTator, text mining | PubMed |
| Whole genome sequence of an uncommon G9P[4] species A rotavirus containing DS-1-like (genotype 2) genes in Japan. | Arch Virol | 2022 | 35568761 | PubTator, text mining | PubMed |
| Molecular interactions and inhibition of the SARS-CoV-2 main protease by a thiadiazolidinone derivative. | Proteins | 2022 | 35567429 | PubTator, text mining | PubMed |
| Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates. | Molecules | 2022 | 35566073 | PubTator, text mining | PubMed |
| Nanoparticles for Coronavirus Control. | Nanomaterials (Basel) | 2022 | 35564311 | PubTator, text mining | PubMed |
| Bioactive Based Nanocarriers for the Treatment of Viral Infections and SARS-CoV-2. | Nanomaterials (Basel) | 2022 | 35564239 | PubTator, text mining | PubMed |
| The Role of Nuclear Factor Kappa B (NF-κB) in Development and Treatment of COVID-19: Review. | Int J Mol Sci | 2022 | 35563673 | PubTator, text mining | PubMed |
| Dimerization Tendency of 3CLpros of Human Coronaviruses Based on the X-ray Crystal Structure of the Catalytic Domain of SARS-CoV-2 3CLpro. | Int J Mol Sci | 2022 | 35563658 | PubTator, text mining | PubMed |
| The Endolysosomal System: The Acid Test for SARS-CoV-2. | Int J Mol Sci | 2022 | 35562967 | PubTator, text mining | PubMed |
| Inhibitors of SARS-CoV-2 PLpro. | Front Chem | 2022 | 35559224 | PubTator, text mining | PubMed |
| Phylogenetic and amino acid signature analysis of the SARS-CoV-2s lineages circulating in Tunisia. | Infect Genet Evol | 2022 | 35552003 | PubTator, text mining | PubMed |
| The role of NSP6 in the biogenesis of the SARS-CoV-2 replication organelle. | Nature | 2022 | 35551511 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=52